Glossary Updates12 new terms added to the glossaries · October 2, 2026, 22:44 CEST
AI TechDocKnowledge

Glossary · ICH guidelines

ICH Q12 (product lifecycle management)

Also known as: Q12, Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management, Established conditions (ECs), PACMP, Product lifecycle management document (PLCM document)

ICH Q12 is the ICH guideline on the technical and regulatory considerations for pharmaceutical product lifecycle management, adopted in 2019. It provides tools to manage chemistry, manufacturing and controls changes after approval more predictably, notably established conditions, post-approval change management protocols and the product lifecycle management document.

  • ICH
  • Pharma

In one sentence

ICH Q12 makes post-approval CMC changes more predictable through established conditions, change management protocols (PACMP) and a PLCM document.

Example

A manufacturer files an ICH Q12 post-approval change management protocol with its application, describing how it will qualify a second API supplier; when the change is made, it submits the data in a lower reporting category than a standalone variation would require.

How it applies

  • Established conditions (ECs): Legally binding elements of the dossier that are considered necessary to assure product quality. Changes to ECs need regulatory notification or approval; other information in the dossier is supportive and can be managed in the company's quality system.
  • Post-approval change management protocol (PACMP): A plan, agreed with the regulator in advance, that describes a future change, the studies to support it and the acceptance criteria, often allowing a lower reporting category when the change is implemented.
  • Product lifecycle management (PLCM) document: A summary of the ECs, their reporting categories and any PACMPs, maintained over the product's life.
  • Precondition: The tools rely on an effective pharmaceutical quality system and on product and process understanding from ICH Q8(R2). Regional legal frameworks decide how far each tool can be used; check the implementation by EMA, FDA or the relevant regulator.
  • Technical documentation: Mark ECs and supportive information clearly in CTD module 3 and keep the PLCM document under change control, so every later change can be classified against it.

ICH Q12 vs. an FDA PCCP

Both agree future changes with the regulator in advance. A PACMP under ICH Q12 is a pharmaceutical tool for CMC changes to medicines. A predetermined change control plan is an FDA device tool, under section 515C of the FD&C Act, for planned modifications to a medical device, used especially for AI-enabled device software functions.